Hosted on MSN26d
Add-On Cemiplimab Shows Promise as First-Line Treatment for Penile Cancer
SAN FRANCISCO -- A combination of cemiplimab (Libtayo) and standard-of-care chemotherapy appeared to be effective in patients with locally advanced or metastatic penile cancer, according to ...
The Scientist2y
Bio-Rad Introduces Anti-Cemiplimab Antibodies
These ready-made antibodies are suitable for developing selective and sensitive assays for bioanalysis and drug monitoring of cemiplimab. Cemiplimab acts as a checkpoint inhibitor by binding to PD-1 ...
MedPage Today27d
Add-On Cemiplimab Shows Promise as First-Line Treatment for Penile Cancer
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN FRANCISCO -- A combination of cemiplimab (Libtayo) and standard-of-care chemotherapy appeared to be effective in ...